EIPG President Prof. Claude Farrugia, and EIPG Vice-Presidents Maurizio Battistini and Piero Iamartino, with AFI President Prof. Alessandro Rigamonti, at the 56° Simposio AFI
Professor Claude Farrugia, resident Associate Professor in the Department of Chemistry within the Faculty of Science, was elected President of the European Industrial Pharmacists Group (EIPG) during the 50th EIPG General Assembly held in Paris, France.
Professor Claude Farrugia, resident Associate Professor in the Department of Chemistry within the Faculty of Science, was elected President of the European Industrial Pharmacists Group (EIPG) during the 50th EIPG General Assembly held in Paris, France.
EIPG is a European association representing the national, professional organisations of pharmacists employed in the pharmaceutical or allied industries of the Member States of the European Union, the European Economic Area, or European countries having a mutual recognition agreement with the European Union on compliance control of regulated medicines. Its foundation dates back to 1966 and, over the years, it has progressed in its activities in line with the evolution of the European Union. Today EIPG represents about 10,000 pharmacists working in the European industry. During the General Assembly in Paris, the Group also organised a scientific symposium on how medicines have changed over the last fifty years, and developments for the future, where Professor Farrugia gave a presentation on the Group’s vision for the future of the sector.
Professor Farrugia is well linked with the pharmaceutical industry both locally and abroad, being active in research in the field of applied chemistry within the pharmaceutical industry, particularly the analysis of of medicinal products and their ingredients. His latest work on the HPLC analysis of Angiotensin II receptor blocker antagonists, co-authored with one of his graduate students, Mr Gustaf Cauchi, and presented at the 56th Symposium of the Italian scientific society Associazione Farmaceutici Industria (AFI), was awarded a special recognition for the important scientific contribution to the event, representing the latest feather in the cap for the Department of Chemistry's ongoing research collaboration with the pharmaceutical industry.